![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Saturday, December 07, 2013 10:09:26 AM
Titan would likely be attacking outside the US and into subspecialties not currently well represented. It will be interesting to see what happens for hospitals currently with DaVinci that want a second robot. Titan May be much less of a capital expenditure.
In response to adding an additional arm- I'm certainly not a biomedical engineer but the rate limiting step is the port site size to accommodate 4 port entry sites. Unless you want a bigger umbilical incision which defeats "scarless " incisions.
If this happens, gen surg will certainly be doing more umbilical hernia repairs, then you can start investing in mesh companies
Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM
ECGI Holdings Targets $9.7 Billion Equestrian Apparel Market with Allon Brand Launch • ECGI • Jun 25, 2024 8:36 AM
Avant Technologies Addresses Progress on AI Supercomputer-Driven Data Centers • AVAI • Jun 25, 2024 8:00 AM
Green Leaf Innovations, Inc. Expands International Presence with New Partnership in Dubai • GRLF • Jun 24, 2024 8:30 AM
Bemax Inc. Positions to Capitalize on Industry Growth with New Improved Quality of Mother's Touch® Disposable Diapers • BMXC • Jun 24, 2024 8:00 AM
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM